{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:35:57Z","timestamp":1785825357703,"version":"3.56.0"},"reference-count":179,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.lfs.2024.123170","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T05:37:53Z","timestamp":1730093873000},"page":"123170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Cardio-oncological dialogue: Understanding the mechanistic correlation between heart failure and cancer"],"prefix":"10.1016","volume":"358","author":[{"given":"Faisal Ashraf","family":"Bhat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saara","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiysha Siddiq","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Ehtaishamul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abul Kalam","family":"Najmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.lfs.2024.123170_bb0005","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1158\/0008-5472.CAN-21-2463","article-title":"Cardiac dysfunction promotes cancer progression via multiple secreted factors","volume":"82","author":"Awwad","year":"2022","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-15639-5","article-title":"Fatal heart disease among cancer patients","volume":"11","author":"Stoltzfus","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0015","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaccao.2021.11.007","article-title":"Cancer incidence and mortality according to pre-existing heart failure in a community-based cohort","volume":"4","author":"Bertero","year":"2022","journal-title":"JACC CardioOncology"},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaccao.2022.01.100","article-title":"Incident cardiovascular Disease among adults with Cancer: population-based cohort study","volume":"4","author":"Paterson","year":"2022","journal-title":"JACC CardioOncology"},{"issue":"5","key":"10.1016\/j.lfs.2024.123170_bb0025","first-page":"1","article-title":"Association between heart failure and the incidence of cancer: a systematic review and meta-analysis","volume":"3","author":"Jaiswal","year":"2023","journal-title":"Eur. Hear. J. Open"},{"issue":"18","key":"10.1016\/j.lfs.2024.123170_bb0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.016309","article-title":"Cancer mortality in trials of heart failure with reduced ejection fraction: a systematic review and meta-analysis","volume":"9","author":"Tini","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.lfs.2024.123170_bb0035","doi-asserted-by":"crossref","unstructured":"\u201cEarly Cardiac Remodeling Promotes Tumor Growth and Metastasis,\u201d pp. 670\u2013683, 2020, doi:https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.046471.","DOI":"10.1161\/CIRCULATIONAHA.120.046471"},{"issue":"2","key":"10.1016\/j.lfs.2024.123170_bb0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/CS20160412","article-title":"An emerging epidemic: cancer and heart failure","volume":"131","author":"Thavendiranathan","year":"2017","journal-title":"Clin. Sci."},{"key":"10.1016\/j.lfs.2024.123170_bb0045","doi-asserted-by":"crossref","unstructured":"S. I. G. Florian R. Greten1, 2, 3, \u201c\u4e73\u9f20\u5fc3\u808c\u63d0\u53d6 HHS Public Access,\u201d Immunity, vol. 51, no. 1, pp. 27\u201341, 2019, doi:https:\/\/doi.org\/10.1016\/j.immuni.2019.06.025.Inflammation.","DOI":"10.1016\/j.immuni.2019.06.025"},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0050","first-page":"1","article-title":"Neoplastic pathogenesis associated with cigarette carcinogens","volume":"11","author":"Hussain","year":"2019","journal-title":"Cureus"},{"issue":"24","key":"10.1016\/j.lfs.2024.123170_bb0055","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1161\/CIRCULATIONAHA.117.031912","article-title":"Cigarette smoking and incident heart failure: insights from the Jackson heart study","volume":"137","author":"Kamimura","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.lfs.2024.123170_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094798","article-title":"Impact of obesity-induced inflammation on cardiovascular diseases (Cvd)","volume":"22","author":"Battineni","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123170_bb0065","article-title":"Exercise, cancer, and the cardiovascular system\u00a0: clinical effects and mechanistic insights","volume":"no. 0123456789","author":"Wernhart","year":"2024","journal-title":"Basic Res. Cardiol."},{"issue":"7","key":"10.1016\/j.lfs.2024.123170_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12071613","article-title":"Clinical significance of clonal hematopoiesis of indeterminate potential in hematology and cardiovascular Disease","volume":"12","author":"Hoermann","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.lfs.2024.123170_bb0075","doi-asserted-by":"crossref","unstructured":"M. A. Sikking et al., \u201cClonal hematopoiesis of indeterminate potential from a heart failure specialist's point of view,\u201d 2023, doi:https:\/\/doi.org\/10.1161\/JAHA.123.030603.","DOI":"10.1161\/JAHA.123.030603"},{"issue":"2","key":"10.1016\/j.lfs.2024.123170_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mco2.218","article-title":"Metabolic reprogramming in cancer: mechanisms and therapeutics","volume":"4","author":"Nong","year":"2023","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of Cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"issue":"7274","key":"10.1016\/j.lfs.2024.123170_bb0090","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.lfs.2024.123170_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12030566","article-title":"Potential mechanisms of cancer-related hypercoagulability","volume":"12","author":"Nasser","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"16","key":"10.1016\/j.lfs.2024.123170_bb0100","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1161\/CIRCULATIONAHA.112.000790","article-title":"Tumors metastatic to the heart","volume":"128","author":"Goldberg","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2024.123170_bb0105","first-page":"565","article-title":"Clinical pathologic comlatlons anatomy, histology, and pathology of the cardiac conduction system-part","volume":"569","author":"Comlatlons","year":"1993"},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0110","first-page":"364","article-title":"Paraneoplastic syndromes","volume":"80","author":"Nielssen","year":"2006","journal-title":"Canine Intern. Med. Secrets"},{"issue":"7","key":"10.1016\/j.lfs.2024.123170_bb0115","first-page":"863","article-title":"HHS Public Access","volume":"32","author":"Moudgil","year":"2017"},{"issue":"11","key":"10.1016\/j.lfs.2024.123170_bb0120","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrc2945","article-title":"The renin-angiotensin system and cancer: old dog, new tricks","volume":"10","author":"George","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.lfs.2024.123170_bb0125","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3748\/wjg.v10.i8.1082","article-title":"Hypoxia-inducible factor-1 in tumour angiogenesis","volume":"10","author":"Shi","year":"2004","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0130","article-title":"Cancer Incidence and mortality according to pre-existing heart failure in a community-based cohort","volume":"4","author":"Cancer","year":"2022"},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04803-2","article-title":"Current evidence regarding the cellular mechanisms associated with cancer progression due to cardiovascular diseases","volume":"22","author":"Attachaipanich","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.lfs.2024.123170_bb0140","doi-asserted-by":"crossref","unstructured":"Y. Du, T. Wu, and R. Madonna, \u201cHeart failure and cancer\u00a0: From active exposure to passive adaption,\u201d no. October, 2022, doi:https:\/\/doi.org\/10.3389\/fcvm.2022.992011.","DOI":"10.3389\/fcvm.2022.992011"},{"key":"10.1016\/j.lfs.2024.123170_bb0145","unstructured":"C. Remodeling and P. Cancer, Early Cardiac Remodeling Promotes Tumor Growth and Metastasis n.d.."},{"issue":"11","key":"10.1016\/j.lfs.2024.123170_bb0150","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.lfs.2024.123170_bb0155","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/1078-0432.CCR-08-0149","article-title":"Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe","volume":"15","author":"Aggarwal","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2024.123170_bb0160","doi-asserted-by":"crossref","DOI":"10.1177\/2050312120965752","article-title":"Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer","volume":"8","author":"Amin","year":"2020","journal-title":"SAGE Open Med."},{"issue":"2","key":"10.1016\/j.lfs.2024.123170_bb0165","doi-asserted-by":"crossref","first-page":"106","DOI":"10.15420\/cfr.2019.1.2","article-title":"Bidirectional relationship between Cancer and heart failure: old and new issues in cardio-oncology","volume":"5","author":"Bertero","year":"2019","journal-title":"Card. Fail. Rev."},{"issue":"9","key":"10.1016\/j.lfs.2024.123170_bb0170","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.lfs.2024.123170_bb0175","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jaccao.2021.08.011","article-title":"Common pathophysiology in Cancer, atrial fibrillation, atherosclerosis, and thrombosis: JACC: CardioOncology state-of-the-art review","volume":"3","author":"Leiva","year":"2021","journal-title":"JACC CardioOncology"},{"issue":"May","key":"10.1016\/j.lfs.2024.123170_bb0180","first-page":"1","article-title":"Interconnected clinical and social risk factors in breast Cancer and heart failure","volume":"9","author":"Sinha","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.lfs.2024.123170_bb0185","doi-asserted-by":"crossref","first-page":"264","DOI":"10.11613\/BM.2011.036","article-title":"Inflammation molecular pathways in cancer-related inflammation","volume":"21","author":"Del Prete Annalisa","year":"2011","journal-title":"Biochemia-medica."},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2024.123170_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200262002-00001","article-title":"The epidemiology of smoking: health consequences and benefits of cessation","volume":"62","author":"Fagerstr\u00f6m","year":"2002","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/j.lfs.2024.123170_bb0195","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.addbeh.2005.11.008","article-title":"Coronary heart disease is the leading cause of death worldwide (McKay & Mensah, 2004), and active smoking has been identified as one of the single most important modifiable risk factors for it","volume":"31","author":"Taylor","year":"2006","journal-title":"Addict. Behav."},{"issue":"12","key":"10.1016\/j.lfs.2024.123170_bb0200","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/oxfordjournals.eurheartj.a061810","article-title":"Acute influence of cigarette smoke in platelets, catecholamines and neurophysins in the normal conditions of daily life","volume":"6","author":"De Lorgeril","year":"1985","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.lfs.2024.123170_bb0205","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/204748739900600403","article-title":"Smoking and risk of stroke","volume":"6","author":"Hankey","year":"1999","journal-title":"J. Cardiovasc. Risk"},{"issue":"10\u201311","key":"10.1016\/j.lfs.2024.123170_bb0210","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0278-6915(97)00063-X","article-title":"An international literature survey of \u2018IARC group I carcinogens\u2019 reported in mainstream cigarette smoke","volume":"35","author":"Smith","year":"1997","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0215","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-015-1617-5","article-title":"Systematic review of cigar smoking and all cause and smoking related mortality","volume":"15","author":"Chang","year":"2015","journal-title":"BMC Public Health"},{"issue":"10","key":"10.1016\/j.lfs.2024.123170_bb0220","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.2174\/138161209787846973","article-title":"Molecular and biochemical changes of the cardiovascular system due to smoking exposure","volume":"15","author":"Armani","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.lfs.2024.123170_bb0225","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/cvr\/cvz035","article-title":"Common risk factors for heart failure and cancer","volume":"115","author":"Meijers","year":"2019","journal-title":"Cardiovasc. Res."},{"issue":"October","key":"10.1016\/j.lfs.2024.123170_bb0230","first-page":"1","article-title":"Obesity and the bidirectional risk of cancer and cardiovascular diseases in African Americans: disparity vs. ancestry","volume":"8","author":"Guha","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"21","key":"10.1016\/j.lfs.2024.123170_bb0235","doi-asserted-by":"crossref","first-page":"E984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular Disease a scientific statement from the American Heart Association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.lfs.2024.123170_bb0240","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/eurheartj\/ehn573","article-title":"Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study","volume":"30","author":"Mahabadi","year":"2009","journal-title":"Eur. Heart J."},{"issue":"7121","key":"10.1016\/j.lfs.2024.123170_bb0245","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nature05487","article-title":"Mechanisms linking obesity with cardiovascular disease","volume":"444","author":"Van Gaal","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2024.123170_bb0250","doi-asserted-by":"crossref","unstructured":"G. J. Koelwyn et al., \u201cMyocardial infarction accelerates breast cancer via innate immune reprogramming,\u201d Nat. Med., doi:https:\/\/doi.org\/10.1038\/s41591-020-0964-7.","DOI":"10.1038\/s41591-020-0964-7"},{"key":"10.1016\/j.lfs.2024.123170_bb0255","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/291546","article-title":"Obesity as a major risk factor for cancer","volume":"2013","author":"De Pergola","year":"2013","journal-title":"J. Obes."},{"issue":"3","key":"10.1016\/j.lfs.2024.123170_bb0260","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/jjco\/hyac210","article-title":"Clonal heamatopoiesis and associated cardiovascular diseases","volume":"53","author":"Tajiri","year":"2023","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"Supplement 1","key":"10.1016\/j.lfs.2024.123170_bb0265","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood-2022-158960","article-title":"Prediction of risk for myeloid malignancy in clonal hematopoiesis","volume":"140","author":"Weeks","year":"2022","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.lfs.2024.123170_bb0270","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/s41591-021-01521-4","article-title":"Distinction of lymphoid and myeloid clonal hematopoiesis","volume":"27","author":"Niroula","year":"2021","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.lfs.2024.123170_bb0275","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41576-021-00356-6","article-title":"Germline risk of clonal haematopoiesis","volume":"22","author":"Silver","year":"2021","journal-title":"Nat. Rev. Genet."},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-018-1540-5","article-title":"CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin","volume":"16","author":"Xu","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.lfs.2024.123170_bb0285","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1517\/14728222.2011.639361","article-title":"The RAS\/RAF\/MEK\/ERK and the PI3K\/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches","volume":"16","author":"De Luca","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.lfs.2024.123170_bb0290","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jacc.2019.05.045","article-title":"Clonal hematopoiesis of indeterminate potential reshapes age-related CVD: JACC review topic of the week","volume":"74","author":"Khetarpal","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0295","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jacc.2021.04.085","article-title":"Supplemental Association of Clonal Hematopoiesis with Incident Heart Failure","volume":"78","author":"Yu","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.lfs.2024.123170_bb0300","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related cancer mutations associated with clonal hematopoietic expansion","volume":"20","author":"Xie","year":"2014","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0305","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"issue":"July","key":"10.1016\/j.lfs.2024.123170_bb0310","first-page":"1","article-title":"Bidirectional relationship between cancer and heart failure: insights on circulating biomarkers","volume":"9","author":"Chianca","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.lfs.2024.123170_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0178607","article-title":"Plasma brain natriuretic peptide levels are elevated in patients with cancer","volume":"12","author":"Bando","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2024.123170_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/VHRM.S166157","article-title":"Biomarkers in acute myocardial infarction: current perspectives","volume":"15","author":"Aydin","year":"2019","journal-title":"Vasc. Health Risk Manag."},{"issue":"12","key":"10.1016\/j.lfs.2024.123170_bb0325","doi-asserted-by":"crossref","DOI":"10.1080\/21548331.1990.11704052","article-title":"Elevated creatine kinase and malignancy","volume":"25","author":"Eng","year":"1990","journal-title":"Hosp. Pract."},{"issue":"4","key":"10.1016\/j.lfs.2024.123170_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13040802","article-title":"Circulating cancer biomarkers","volume":"13","author":"Lokshin","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.lfs.2024.123170_bb0335","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1039\/C4CS00370E","article-title":"Cancer biomarker detection: recent achievements and challenges","volume":"44","author":"Wu","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.lfs.2024.123170_bb0340","doi-asserted-by":"crossref","unstructured":"R. A. De Boer et al., \u201cA new classification of cardio-oncology syndromes,\u201d pp. 1\u201317, 2021.","DOI":"10.1186\/s40959-021-00110-1"},{"issue":"13","key":"10.1016\/j.lfs.2024.123170_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311091","article-title":"Clinical and biological predictors of Cancer incidence and mortality in patients with stable coronary artery Disease","volume":"24","author":"Campolo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2024.123170_bb0350","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.critrevonc.2010.11.004","article-title":"Circulating microRNAs: association with disease and potential use as biomarkers","volume":"80","author":"Reid","year":"2011","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.lfs.2024.123170_bb0355","series-title":"AHA Scientific Statement Exercise and Heart Failure A Statement From the American Heart Association Committee on Exercise, Rehabilitation, and Prevention","first-page":"1210","author":"Pi\u00f1a","year":"2003"},{"key":"10.1016\/j.lfs.2024.123170_bb0360","first-page":"1","article-title":"Predictors of lower exercise capacity in patients with cancer","author":"Evertz","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.lfs.2024.123170_bb0365","article-title":"Impaired Exercise Capacity and Mortality Risk in Adults With Congenital Heart Disease","volume":"2","year":"2023"},{"key":"10.1016\/j.lfs.2024.123170_bb0370","series-title":"The Benefits of Exercise in Cancer Patients and the Criteria For Exercise Prescription in Cardio-Oncology","author":"Ascenzi","year":"2019"},{"issue":"6","key":"10.1016\/j.lfs.2024.123170_bb0375","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41569-022-00698-6","article-title":"Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer","volume":"19","author":"Karlstaedt","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"November","key":"10.1016\/j.lfs.2024.123170_bb0380","article-title":"Cancer\u2014a major cardiac comorbidity with implications on cardiovascular metabolism","volume":"12","author":"Finke","year":"2021","journal-title":"Front. Physiol."},{"issue":"June 2022","key":"10.1016\/j.lfs.2024.123170_bb0385","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.yjmcc.2022.06.008","article-title":"Cardio-onco-metabolism \u2013 metabolic vulnerabilities in cancer and the heart","volume":"171","author":"Karlstaedt","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"22","key":"10.1016\/j.lfs.2024.123170_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213902","article-title":"Oncometabolism: a paradigm for the metabolic remodeling of the failing heart","volume":"23","author":"Kuhn","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"January","key":"10.1016\/j.lfs.2024.123170_bb0395","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.thromres.2018.01.003","article-title":"Arterial thrombosis and cancer","volume":"164","author":"Aronson","year":"2018","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.lfs.2024.123170_bb0400","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaccao.2021.03.001","article-title":"Venous and arterial thromboembolism in patients with Cancer: JACC: CardioOncology state-of-the-art review","volume":"3","author":"Gervaso","year":"2021","journal-title":"JACC CardioOncology"},{"issue":"9","key":"10.1016\/j.lfs.2024.123170_bb0405","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.21873\/anticanres.13642","article-title":"Arterial thrombosis in cancer: spotlight on the neglected vessels","volume":"39","author":"Canale","year":"2019","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0410","article-title":"Arterial and venous thrombosis in cancer patients","volume":"1","author":"Blann","year":"2011","journal-title":"Cardiol. Res. Pract."},{"issue":"2","key":"10.1016\/j.lfs.2024.123170_bb0415","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jth.12075","article-title":"Coagulation and cancer: biological and clinical aspects","volume":"11","author":"Falanga","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"August","key":"10.1016\/j.lfs.2024.123170_bb0420","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.critrevonc.2017.08.003","article-title":"Mechanisms and risk factors of thrombosis in cancer","volume":"118","author":"Falanga","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"6","key":"10.1016\/j.lfs.2024.123170_bb0425","first-page":"6S8","article-title":"Cancer and thrombosis: new insights to an old problem","volume":"45","author":"Leiva","year":"2020","journal-title":"JMV-J. Med. Vasc."},{"key":"10.1016\/j.lfs.2024.123170_bb0430","first-page":"103","article-title":"Mechanisms of cancer-induced thrombosis","volume":"2","author":"Rickles","year":"2006"},{"issue":"3","key":"10.1016\/j.lfs.2024.123170_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031257","article-title":"Neutrophils, Cancer and thrombosis: the new Bermuda triangle in Cancer research","volume":"23","author":"Langiu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"36","key":"10.1016\/j.lfs.2024.123170_bb0440","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0445","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/jcp.2005.035105","article-title":"cardiac metastasis","volume":"60","author":"Bussani","year":"2007","journal-title":"J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.lfs.2024.123170_bb0450","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1148\/radiographics.21.2.g01mr15439","article-title":"Metastatic involvement of the heart and pericardium: CT and MR imaging","volume":"21","author":"Chiles","year":"2001","journal-title":"Radiographics"},{"key":"10.1016\/j.lfs.2024.123170_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7819-11-14","article-title":"Symptomatic cardiac metastases of breast cancer 27 years after mastectomy: a case report with literature review - pathophysiology of molecular mechanisms and metastatic pathways, clinical aspects, diagnostic procedures and treatment modalities","volume":"11","author":"Katalinic","year":"2013","journal-title":"World J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.lfs.2024.123170_bb0460","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCEP.110.961193","article-title":"Radiofrequency catheter ablation of life-threatening ventricular arrhythmias caused by left ventricular metastatic infiltration","volume":"4","author":"Casella","year":"2011","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"2","key":"10.1016\/j.lfs.2024.123170_bb0465","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/2320-8775.183838","article-title":"Cardiac metastasis of lung cancer: case report and review of literature","volume":"4","author":"Prasad","year":"2016","journal-title":"J. Assoc. Chest Physicians"},{"key":"10.1016\/j.lfs.2024.123170_bb0470","article-title":"M 2,107","volume":"61","author":"Kline","year":"1971"},{"issue":"2","key":"10.1016\/j.lfs.2024.123170_bb0475","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/svms.2003.36629","article-title":"Common paraneoplastic syndromes","volume":"18","author":"Finora","year":"2003","journal-title":"Clin. Tech. Small Anim. Pract."},{"key":"10.1016\/j.lfs.2024.123170_bb0480","article-title":"Hypercalcemia and the cardiovascular system","volume":"no. 30","author":"Karthikeyan","year":"2006","journal-title":"Hear. Metab."},{"issue":"11","key":"10.1016\/j.lfs.2024.123170_bb0485","first-page":"371","article-title":"Unexpected prolonged extreme hypocalcaemia and an inadequate PTH response in a patient with metastatic breast carcinoma","volume":"61","author":"Bergkamp","year":"2003","journal-title":"Neth. J. Med."},{"issue":"2","key":"10.1016\/j.lfs.2024.123170_bb0490","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3892\/ol.2015.3326","article-title":"Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: a case report and literature review","volume":"10","author":"Farolfi","year":"2015","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.lfs.2024.123170_bb0495","doi-asserted-by":"crossref","first-page":"E955","DOI":"10.1210\/clinem\/dgab794","article-title":"Severe hypoglycemia and incident heart failure among adults with type 2 diabetes","volume":"107","author":"Echouffo-Tcheugui","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.lfs.2024.123170_bb0500","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ehf2.12184","article-title":"Cardiac muscle wasting in individuals with cancer cachexia","volume":"4","author":"Barkhudaryan","year":"2017","journal-title":"ESC Hear. Fail."},{"issue":"01","key":"10.1016\/j.lfs.2024.123170_bb0505","first-page":"645","article-title":"Cancer anorexia and Cachexia","volume":"9007","author":"Heber","year":"2006","journal-title":"Nutr. Oncol. Second Ed."},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0510","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1517\/14728214.2012.652946","article-title":"Editorial update on emerging drugs for cancer cachexia","volume":"17","author":"Murphy","year":"2012","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"4","key":"10.1016\/j.lfs.2024.123170_bb0515","doi-asserted-by":"crossref","first-page":"H466","DOI":"10.1152\/ajpheart.00720.2015","article-title":"The pathogenesis and treatment of cardiac atrophy in cancer cachexia","volume":"310","author":"Murphy","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.lfs.2024.123170_bb0520","first-page":"1321","article-title":"Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice","volume":"39","author":"Tian","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2024.123170_bb0525","first-page":"547","article-title":"Cardiac alterations in cancer-induced cachexia in mice","volume":"35","author":"Tian","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2024.123170_bb0530","article-title":"Clinical update cancer drugs and the heart\u00a0: importance and management","volume":"I","author":"Suter","year":"2012","journal-title":"Type"},{"issue":"3","key":"10.1016\/j.lfs.2024.123170_bb0535","article-title":"Treatment of chemotherapy-associated cardiomyopathy","volume":"34","author":"Cai","year":"2019"},{"key":"10.1016\/j.lfs.2024.123170_bb0540","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejca.2023.02.019","article-title":"Anthracycline-induced cardiotoxicity \u2014 are we about to clear this hurdle?","volume":"185","author":"Dempke","year":"2023","journal-title":"Eur. J. Cancer"},{"issue":"May","key":"10.1016\/j.lfs.2024.123170_bb0545","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.toxrep.2024.05.003","article-title":"Mitigation of cisplatin-induced cardiotoxicity by isorhamnetin: mechanistic insights into oxidative stress, inflammation, and apoptosis modulation","volume":"12","author":"Abudalo","year":"2024","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.lfs.2024.123170_bb0550","doi-asserted-by":"crossref","unstructured":"Q. Wu et al., \u201cThe molecular mechanisms of cardiotoxicity induced by HER2, VEGF, and tyrosine kinase inhibitors: an updated review,\u201d 2021.","DOI":"10.1007\/s10557-021-07181-3"},{"key":"10.1016\/j.lfs.2024.123170_bb0555","first-page":"1","article-title":"Exploring the cardiotoxicity spectrum of anti-cancer treatments: definition, classification, and diagnostic pathways","volume":"no. Ici","author":"Mauro","year":"2023"},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2024.123170_bb0560","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ajhp\/61.suppl_2.S4","article-title":"Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure","volume":"61","author":"Adams","year":"2004","journal-title":"Am. J. Heal. Pharm."},{"key":"10.1016\/j.lfs.2024.123170_bb0565","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijcard.2016.03.080","article-title":"The pathophysiological role of natriuretic peptide-RAAS cross talk in heart failure","volume":"226","author":"Rossi","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"7364","key":"10.1016\/j.lfs.2024.123170_bb0570","first-page":"349","article-title":"NIH Public Access","volume":"477","author":"Hara","year":"2013"},{"issue":"7","key":"10.1016\/j.lfs.2024.123170_bb0575","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1161\/CIRCULATIONAHA.118.033603","article-title":"Linking heart failure to cancer background evidence and research perspectives","volume":"138","author":"Bertero","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2024.123170_bb0580","series-title":"Tumor Associated Macrophages and Neutrophils in Tumor Progression","first-page":"1404","author":"Jaillon","year":"2012"},{"issue":"6","key":"10.1016\/j.lfs.2024.123170_bb0585","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2021.10898","article-title":"Mechanism and prevention strategy of a bidirectional relationship between heart failure and cancer (review)","volume":"22","author":"Cai","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.lfs.2024.123170_bb0590","series-title":"New-Onset Cancer in the HF Population\u00a0: Epidemiology, Pathophysiology, and Clinical Management","first-page":"191","author":"Cuomo","year":"2021"},{"issue":"SUPPL.6","key":"10.1016\/j.lfs.2024.123170_bb0595","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2967\/jnumed.107.045914","article-title":"Molecular imaging of hypoxia","volume":"49","author":"Krohn","year":"2008","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/j.lfs.2024.123170_bb0600","first-page":"51","article-title":"Hypoxia-inducible factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia","volume":"80","author":"Ziello","year":"2007","journal-title":"Yale J. Biol. Med."},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0605","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0006-2952(99)00292-0","article-title":"Expression of hypoxia-inducible factor 1: mechanisms and consequences","volume":"59","author":"Semenza","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123170_bb0610","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-physiol-021113-170322","article-title":"Hypoxia-inducible factor 1 and cardiovascular disease","volume":"76","author":"Semenza","year":"2014","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.lfs.2024.123170_bb0615","series-title":"Reverse Cardio-Oncology: Cancer Development in Patients With","first-page":"1","author":"Aboumsallem","year":"2019"},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0620","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1378\/chest.14-0500","article-title":"Intermittent hypoxemia and OSA implications for comorbidities","volume":"147","author":"Dewan","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.lfs.2024.123170_bb0625","series-title":"Molecular Pathways: Beta-Adrenergic Signaling in Cancer Molecular Pathways: Beta-Adrenergic Signaling in Cancer","first-page":"1201","author":"Cole","year":"2012"},{"issue":"18","key":"10.1016\/j.lfs.2024.123170_bb0630","first-page":"7042","article-title":"The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer","volume":"70","author":"Sloan","year":"2010"},{"key":"10.1016\/j.lfs.2024.123170_bb0635","series-title":"Pancreatology Chronic Stress Increases Experimental Pancreatic Cancer Growth, Reduces Survival and can be Antagonised by Beta-Adrenergic Receptor Blockade K a","first-page":"1","article-title":"et al.","author":"Seubert","year":"2016"},{"key":"10.1016\/j.lfs.2024.123170_bb0640","series-title":"Propranolol Sensitizes Thyroid Cancer Cells to Cytotoxic Effect of Vemurafenib","first-page":"1576","author":"Wei","year":"2016"},{"key":"10.1016\/j.lfs.2024.123170_bb0645","doi-asserted-by":"crossref","unstructured":"S. Maccari et al., \u201cBiphasic effects of propranolol on tumour growth in B16F10 melanoma- bearing mice\u201d, doi:https:\/\/doi.org\/10.1111\/bph.13662.","DOI":"10.1111\/bph.13662"},{"issue":"2","key":"10.1016\/j.lfs.2024.123170_bb0650","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/jid.2014.373","article-title":"Inhibition of human melanoma growth by a non-cardioselective b -blocker","volume":"135","author":"Wrobel","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.lfs.2024.123170_bb0655","first-page":"179","article-title":"Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?","volume":"352","author":"Lever","year":"1998"},{"key":"10.1016\/j.lfs.2024.123170_bb0660","first-page":"2000","article-title":"Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis","volume":"November 2001","author":"Niu","year":"2008"},{"key":"10.1016\/j.lfs.2024.123170_bb0665","doi-asserted-by":"crossref","unstructured":"O. Arrieta et al., \u201cAssociation Between AT1 and AT2 Angiotensin II Receptor Expression with Cell Proliferation and Angiogenesis in Operable Breast Cancer,\u201d 2015, doi:https:\/\/doi.org\/10.1007\/s13277-015-3235-3.","DOI":"10.1007\/s13277-015-3235-3"},{"key":"10.1016\/j.lfs.2024.123170_bb0670","doi-asserted-by":"crossref","unstructured":"H. K. Rooprai, A. Kandanearatchi, S. L. Maidment, and M. Christidou, \u201cEvaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro,\u201d pp. 29\u201339, 2001.","DOI":"10.1046\/j.0305-1846.2000.00298.x"},{"key":"10.1016\/j.lfs.2024.123170_bb0675","series-title":"Inhibition of Matrix Metalloproteinase Activity and Growth of Gastric Adenocarcinoma Cells by an Angiotensin Converting Enzyme Inhibitor in In Vitro and Murine Models","first-page":"1042","author":"Williams","year":"2005"},{"key":"10.1016\/j.lfs.2024.123170_bb0680","article-title":"Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinoma","volume":"no. 123","author":"Chen","year":"2015"},{"key":"10.1016\/j.lfs.2024.123170_bb0685","series-title":"Functional Expression of Sodium-Glucose Transporters in Cancer","author":"Scafoglio","year":"2015"},{"key":"10.1016\/j.lfs.2024.123170_bb0690","series-title":"Effect of Dapagliflozin and\/or L-Arginine on Solid Tumor Model in Mice: The Interaction Between Nitric Oxide, Transforming Growth Factor-Beta 1, Autophagy, and Apoptosis","first-page":"1","author":"Kabel","year":"2021"},{"key":"10.1016\/j.lfs.2024.123170_bb0695","first-page":"510","article-title":"Na-K-2Cl cotransporter inhibition impairs human lung cellular proliferation","volume":"96826","author":"Iwamoto","year":"2004"},{"issue":"14","key":"10.1016\/j.lfs.2024.123170_bb0700","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1096\/fj.03-0129com","article-title":"Differential regulation of in vivo angiogenesis by angiotensin II receptors","volume":"17","author":"Walther","year":"2003","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.lfs.2024.123170_bb0705","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1470-2045(10)70106-6","article-title":"Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials","volume":"11","author":"Sipahi","year":"2010","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.lfs.2024.123170_bb0710","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11906-999-0023-8","article-title":"Carcinogenicity of cardiovascular drugs","volume":"1","author":"Grossman","year":"1999","journal-title":"Curr. Hypertens. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2024.123170_bb0715","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1067\/mhj.2003.166","article-title":"Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects","volume":"145","author":"Licata","year":"2003","journal-title":"Am. Heart J."},{"issue":"May","key":"10.1016\/j.lfs.2024.123170_bb0720","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.canep.2017.08.012","article-title":"Calcium channel blockers and breast cancer incidence: an updated systematic review and meta-analysis of the evidence","volume":"50","author":"Wright","year":"2017","journal-title":"Cancer Epidemiol."},{"issue":"21","key":"10.1016\/j.lfs.2024.123170_bb0725","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.112.150656","article-title":"Cardiokines: recent progress in elucidating the cardiac secretome","volume":"126","author":"Shimano","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2024.123170_bb0730","article-title":"The role of cardiokines in heart diseases: beneficial or detrimental?","volume":"2018","author":"Wu","year":"2018","journal-title":"Biomed. Res. Int."},{"issue":"October","key":"10.1016\/j.lfs.2024.123170_bb0735","first-page":"1","article-title":"Development of Cancer in patients with heart failure: how systemic inflammation can lay the groundwork","volume":"7","author":"Ausoni","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.lfs.2024.123170_bb0740","article-title":"Hsp20 functions as a novel cardiokine in promoting angiogenesis via activation of VEGFR2","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.lfs.2024.123170_bb0745","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.tem.2020.10.004","article-title":"Insights into mechanisms of GDF15 and receptor GFRAL: therapeutic targets","volume":"31","author":"Rochette","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.lfs.2024.123170_bb0750","first-page":"1452","article-title":"HHS Public Access","volume":"26","author":"Koelwyn","year":"2021"},{"issue":"7","key":"10.1016\/j.lfs.2024.123170_bb0755","doi-asserted-by":"crossref","DOI":"10.3390\/cells11071108","article-title":"Cardiac remodeling in the absence of cardiac contractile dysfunction is sufficient to promote Cancer progression","volume":"11","author":"Awwad","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2024.123170_bb0760","first-page":"1","article-title":"Increased risk of non-hematological cancer in young patients with aortic stenosis\u00a0: a retrospective cohort study","author":"Saliba","year":"2021","journal-title":"Cardio-Oncology"},{"key":"10.1016\/j.lfs.2024.123170_bb0765","unstructured":"L. Awwad and A. Aronheim, \u201cTumor progression reverses cardiac hypertrophy and fibrosis,\u201d 2023."},{"issue":"April","key":"10.1016\/j.lfs.2024.123170_bb0770","first-page":"1","article-title":"Coronary atherosclerotic disease and cancer: risk factors and interrelation","volume":"9","author":"Li","year":"2022"},{"issue":"June","key":"10.1016\/j.lfs.2024.123170_bb0775","first-page":"64","article-title":"Diabetes mellitus as one of the risk factors contribute to carcinogenesis","volume":"14","author":"Sutandyo","year":"2020"},{"key":"10.1016\/j.lfs.2024.123170_bb0780","doi-asserted-by":"crossref","unstructured":"V. A. Katzke, R. Kaaks, and T. K\u00fchn, \u201cLifestyle and cancer risk,\u201d pp. 104\u2013110, 2015.","DOI":"10.1097\/PPO.0000000000000101"},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2024.123170_bb0785","first-page":"97","article-title":"A cancer of the blood vessels?","volume":"116","author":"Ross","year":"2001"},{"key":"10.1016\/j.lfs.2024.123170_bb0790","unstructured":"D. L. Antonio, J. Antonio, Q. Rico, and D. Orozco-beltr, \u201cRisk factors for cancer mortality in Spain: population-based cohort study,\u201d 2022."},{"key":"10.1016\/j.lfs.2024.123170_bb0795","article-title":"Data on left ventricular expression of STAT3 and AKT in transgenic mouse models with B16F10 melanoma","volume":"26","author":"Pietzsch","year":"2019","journal-title":"Data Br."},{"issue":"10","key":"10.1016\/j.lfs.2024.123170_bb0800","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.93098","article-title":"Insulin supplementation attenuates cancer-induced cardiomyopathy and slows tumor disease progression","volume":"2","author":"Thackeray","year":"2017","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.lfs.2024.123170_bb0805","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jcsm.12100","article-title":"Nutritional leucine supplementation attenuates cardiac failure in tumour-bearing cachectic animals","volume":"7","author":"Toneto","year":"2016","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.lfs.2024.123170_bb0810","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s13539-013-0116-8","article-title":"Disruption of pro-oxidant and antioxidant systems with elevated expression of the ubiquitin proteosome system in the cachectic heart muscle of nude mice","volume":"4","author":"Hinch","year":"2013","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.lfs.2024.123170_bb0815","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/jcsm.12116","article-title":"Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation","volume":"7","author":"Musolino","year":"2016","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"12","key":"10.1016\/j.lfs.2024.123170_bb0820","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0226440","article-title":"Impaired cardiac performance, protein synthesis, and mitochondrial function in tumor-bearing mice","volume":"14","author":"Berent","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0825","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/rco2.18","article-title":"Cancer-induced cardiac atrophy adversely affects myocardial redox state and mitochondrial oxidative characteristics","volume":"4","author":"Lee","year":"2021","journal-title":"JCSM Rapid Commun."},{"issue":"3","key":"10.1016\/j.lfs.2024.123170_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2019.07.014","article-title":"Modulation of cardiac AKT and STAT3 signalling in preclinical cancer models and their impact on the heart","volume":"1867","author":"Pietzsch","year":"2020","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"issue":"6","key":"10.1016\/j.lfs.2024.123170_bb0835","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/jcsm.12615","article-title":"Cancer cachexia in a mouse model of oxidative stress","volume":"11","author":"Brown","year":"2020","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"14","key":"10.1016\/j.lfs.2024.123170_bb0840","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/eht302","article-title":"Prevention of liver cancer cachexia-induced cardiac wasting and heart failure","volume":"35","author":"Springer","year":"2014","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.lfs.2024.123170_bb0845","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.117.030816","article-title":"Heart failure stimulates tumor growth by circulating factors","volume":"138","author":"Meijers","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2024.123170_bb0850","first-page":"547","article-title":"Accumulation of aberrant CpG hypermethylation by helicobacter pylori infection promotes development","volume":"35","author":"Kondo","year":"2009","journal-title":"Int. J. Oncol."},{"issue":"9\u201310","key":"10.1016\/j.lfs.2024.123170_bb0855","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.lfs.2010.12.010","article-title":"Myocardial dysfunction in an animal model of cancer cachexia","volume":"88","author":"Xu","year":"2011","journal-title":"Life Sci."},{"issue":"48","key":"10.1016\/j.lfs.2024.123170_bb0860","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1093\/eurheartj\/ehz587","article-title":"The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: a cohort study","volume":"40","author":"Van\u2019t Klooster","year":"2019","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.lfs.2024.123170_bb0865","doi-asserted-by":"crossref","first-page":"95","DOI":"10.15537\/smj.2021.1.25618","article-title":"Proteus syndrome caused by novel somatic AKT1 duplication","volume":"42","author":"AlAnzi","year":"2021","journal-title":"Saudi Med. J."},{"issue":"3","key":"10.1016\/j.lfs.2024.123170_bb0870","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jacc.2016.04.053","article-title":"Heart failure after myocardial infarction is associated with increased risk of cancer","volume":"68","author":"Hasin","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.lfs.2024.123170_bb0875","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/annonc\/mdw604","article-title":"Causes of death among cancer patients","volume":"28","author":"Zaorsky","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lfs.2024.123170_bb0880","doi-asserted-by":"crossref","unstructured":"J. Kersten, V. Fink, M. Kersten, L. May, and S. Nunn, \u201cCMR reveals myocardial damage from cardiotoxic oncologic therapies in breast cancer patients,\u201d vol. 4883, pp. 0\u20133, 2023.","DOI":"10.1101\/2023.04.21.23288954"},{"issue":"5","key":"10.1016\/j.lfs.2024.123170_bb0885","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.3892\/or.2017.5542","article-title":"Cancer-induced cardiac cachexia: pathogenesis and impact of physical activity (review)","volume":"37","author":"Belloum","year":"2017","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.lfs.2024.123170_bb0890","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/ejhf.1165","article-title":"Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge","volume":"20","author":"Ameri","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"10.1016\/j.lfs.2024.123170_bb0895","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199007263230405","article-title":"Elevated circulating levels of tumor necrosis factor in severe chronic heart failure","volume":"323","author":"Levine","year":"1990","journal-title":"N. Engl. J. Med."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524007604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524007604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:40:31Z","timestamp":1736185231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524007604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":179,"alternative-id":["S0024320524007604"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123170","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardio-oncological dialogue: Understanding the mechanistic correlation between heart failure and cancer","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123170"}}